You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 1, January 10, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (33)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Critical Care/ Intensive Care Medicine
 •Adult Critical Care
 •Evidence-Based Medicine
 •Review
 •Alert me on articles by topic

Vasopressin for Cardiac Arrest

A Systematic Review and Meta-analysis

KoKo Aung, MD, MPH; Thwe Htay, MD

Arch Intern Med. 2005;165:17-24.

Background  The current guidelines for cardiopulmonary resuscitation recommend vasopressin as an alternative to epinephrine for the treatment of adult shock-refractory ventricular fibrillation. The objective of this study was to determine the effectiveness of vasopressin in the treatment of cardiac arrest.

Methods  We performed a systematic review and meta-analysis of 1519 patients with cardiac arrest from 5 randomized controlled trials that compared vasopressin and epinephrine. Two reviewers conducted a systematic search of electronic databases, complemented by hand searches, to identify randomized trials. Reviewers evaluated the quality of the trials, extracted data, and derived pooled estimates using a random-effects model.

Results  There were no statistically significant differences between the vasopressin and epinephrine groups in failure of return of spontaneous circulation (risk ratio [RR], 0.81; 95% confidence interval [CI], 0.58-1.12), death before hospital admission (RR, 0.72; 95% CI, 0.38-1.39), death within 24 hours (RR, 0.74; 95% CI, 0.38-1.43), death before hospital discharge (RR, 0.96; 95% CI, 0.87-1.05), or combination of number of deaths and neurologically impaired survivors (RR, 1.00; 95% CI, 0.94-1.07). Subgroup analysis based on initial cardiac rhythm showed no statistically significant difference in the rate of death before hospital discharge between the vasopressin and epinephrine groups in any of the 3 subgroups: ventricular fibrillation or ventricular tachycardia (RR, 0.97; 95% CI, 0.79-1.19), pulseless electrical activity (RR, 1.02; 95% CI, 0.95-1.10), or asystole (RR, 0.97; 95% CI, 0.94-1.00).

Conclusions  There is no clear advantage of vasopressin over epinephrine in the treatment of cardiac arrest. Guidelines for Advanced Cardiac Life Support should not recommend vasopressin in resuscitation protocols until more solid human data on its superiority are available.


Author Affiliations: Department of Internal Medicine, Texas Tech University Health Sciences Center, Odessa (Dr Aung); and Diabetes Center of the Southwest, Midland, Tex (Dr Htay).


RELATED LETTER

Vasopressin Has Cost and Administration Advantages Over Epinephrine in Cardiac Arrest
Daniel D. Buff
Arch Intern Med. 2005;165(14):1663.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vasopressin and Epinephrine vs. Epinephrine Alone in Cardiopulmonary Resuscitation
Gueugniaud et al.
NEJM 2008;359:21-30.
ABSTRACT | FULL TEXT  

Cardiopulmonary Resuscitation
Anstadt and Lowe
Card Surg Adult 2008;3:487-506.
FULL TEXT  

Recent advances and controversies in adult cardiopulmonary resuscitation
Ibrahim
Postgrad. Med. J. 2007;83:649-654.
ABSTRACT | FULL TEXT  

The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support
The International Liaison Committee on Resuscitati
Pediatrics 2006;117:e955-e977.
ABSTRACT | FULL TEXT  

Part 7.2: Management of Cardiac Arrest
Circulation 2005;112:IV-58-IV-66.
FULL TEXT  

Major Changes in the 2005 AHA Guidelines for CPR and ECC: Reaching the Tipping Point for Change
Hazinski et al.
Circulation 2005;112:IV-206-IV-211.
FULL TEXT  

Part 4: Advanced Life Support
Circulation 2005;112:III-25-III-54.
FULL TEXT  

Part 6: Pediatric Basic and Advanced Life Support
Circulation 2005;112:III-73-III-90.
FULL TEXT  

Controversial Topics From the 2005 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations
Hazinski et al.
Circulation 2005;112:III-133-III-136.
FULL TEXT  

The Resuscitation Outcome: Revisit the Story of the Stony Heart
El-Menyar
Chest 2005;128:2835-2846.
ABSTRACT | FULL TEXT  

Vasopressin in Cardiac Arrest
Koshman et al.
The Annals of Pharmacotherapy 2005;39:1687-1692.
ABSTRACT | FULL TEXT  

Vasopressin Has Cost and Administration Advantages Over Epinephrine in Cardiac Arrest
Buff
Arch Intern Med 2005;165:1663-1663.
FULL TEXT  

JournalScan
Malik
Heart 2005;91:414-416.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.